Evidence map›Paper›PMID 36809006›Full record

ArticleJCO clinical cancer informatics2023

Toward Predicting 30-Day Readmission Among Oncology Patients: Identifying Timely and Actionable Risk Factors.

Sy Hwang, Ryan Urbanowicz, Selah Lynch, Tawnya Vernon, Kellie Bresz, Carolina Giraldo, Erin Kennedy, Max Leabhart, Troy Bleacher, Michael R Ripchinski and 2 more

Abstract read
In one paragraph

Article in JCO clinical cancer informatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sy HwangInstitute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA.
Ryan UrbanowiczInstitute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA.
Selah LynchDepartment of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania, Philadelphia, PA.
Tawnya VernonAnn B. Barshinger Cancer Institute (ABBCI), University of Pennsylvania, Philadelphia, PA.
Kellie BreszAnn B. Barshinger Cancer Institute (ABBCI), University of Pennsylvania, Philadelphia, PA.
Carolina GiraldoAnn B. Barshinger Cancer Institute (ABBCI), University of Pennsylvania, Philadelphia, PA.
Erin KennedyDepartment of Nursing, University of Pennsylvania, Philadelphia, PA.
Max LeabhartAnn B. Barshinger Cancer Institute (ABBCI), University of Pennsylvania, Philadelphia, PA.
Troy BleacherAnn B. Barshinger Cancer Institute (ABBCI), University of Pennsylvania, Philadelphia, PA.
Michael R RipchinskiAnn B. Barshinger Cancer Institute (ABBCI), University of Pennsylvania, Philadelphia, PA.
Danielle L MoweryInstitute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0003-3802-4457
Randall A OyerAnn B. Barshinger Cancer Institute (ABBCI), University of Pennsylvania, Philadelphia, PA.ORCID 0000-0001-7554-4166

Funding

Phenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4M
Determining Barriers to Achieving Optimal Post-Acute Care DestinationsF31NR019919 · NINR · UNIVERSITY OF PENNSYLVANIA · PI KENNEDY, ERIN · 2021 to 2021
$37k
NCATS NIH HHS UL1 TR001878NINR NIH HHS F31 NR019919
6 · The paper itself

Abstract

purposePredicting 30-day readmission risk is paramount to improving the quality of patient care. In this study, we compare sets of patient-, provider-, and community-level variables that are available at two different points of a patient's inpatient encounter (first 48 hours and the full encounter) to train readmission prediction models and identify possible targets for appropriate interventions that can potentially reduce avoidable readmissions.

methodsUsing electronic health record data from a retrospective cohort of 2,460 oncology patients and a comprehensive machine learning analysis pipeline, we trained and tested models predicting 30-day readmission on the basis of data available within the first 48 hours of admission and from the entire hospital encounter.

resultsLeveraging all features, the light gradient boosting model produced higher, but comparable performance (area under receiver operating characteristic curve [AUROC]: 0.711) with the Epic model (AUROC: 0.697). Given features in the first 48 hours, the random forest model produces higher AUROC (0.684) than the Epic model (AUROC: 0.676). Both models flagged patients with a similar distribution of race and sex; however, our light gradient boosting and random forest models were more inclusive, flagging more patients among younger age groups. The Epic models were more sensitive to identifying patients with an average lower zip income. Our 48-hour models were powered by novel features at various levels: patient (weight change over 365 days, depression symptoms, laboratory values, and cancer type), hospital (winter discharge and hospital admission type), and community (zip income and marital status of partner).

conclusionWe developed and validated models comparable with the existing Epic 30-day readmission models with several novel actionable insights that could create service interventions deployed by the case management or discharge planning teams that may decrease readmission rates over time.

Indexed as

NeoplasmsPatient ReadmissionHospitalizationHumansRetrospective StudiesRisk Factors

Identifiers

PMID36809006
PMCPMC10476733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.